Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | ENPEP | Q07075 | 7/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 4/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.46 |
| ▸ | FPR2 | P25090 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | MME | P08473 | 1/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.43 |
| ▸ | CPA1 | P15085 | 1/20 | 0.43 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31025662 | 1.00 | ALDH1A1 (0.58) | ALDH1A1ENPEPL3MBTL1CA2CA1 | |
| SCHEMBL7441174 | 1.00 | ALDH1A1 (0.58) | ALDH1A1ENPEPL3MBTL1CA2CA1 | |
| SCHEMBL2933766 | 1.00 | ALDH1A1 (0.58) | ALDH1A1ENPEPL3MBTL1CA2CA1 | |
| SCHEMBL22210773 | 0.96 | ALDH1A1 (0.54) | ALDH1A1ENPEPL3MBTL1CA2CA1 | |
| SCHEMBL29577673 | 0.96 | ALDH1A1 (0.54) | ALDH1A1ENPEPL3MBTL1CA2CA1 | |
| SCHEMBL30011128 | 0.96 | ALDH1A1 (0.54) | ALDH1A1ENPEPL3MBTL1CA2CA1 | |
| SCHEMBL2739558 | 0.94 | ALDH1A1 (0.59) | ALDH1A1ENPEPL3MBTL1CA2CA1 | |
| SCHEMBL29707133 | 0.93 | ALDH1A1 (0.51) | ALDH1A1ENPEPL3MBTL1CA2CA1 | |
| SCHEMBL4982161 | 0.93 | ALDH1A1 (0.51) | ALDH1A1ENPEPL3MBTL1CA2CA1 | |
| SCHEMBL29906310 | 0.93 | ALDH1A1 (0.51) | ALDH1A1ENPEPL3MBTL1CA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695413-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | Ohio State Innovation Foundation (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4659591-A1 | TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT | House Foods Group Inc. (JP) | 2025-12-10 | — | — | EP | claimed |
| WO-2024216031-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2024-10-17 | — | — | WO | claimed |
| CN-118557698-A | Application of urechis unicinctus modified polypeptide in preparation of drug for treating alcoholic liver injury | 北京石油化工学院 | 2024-08-30 | — | — | CN | claimed |
| WO-2024163598-A2 | PEPTIDES COMPRISING THIOESTER GROUPS, INCLUDING DEPSIPEPTIDE THIOESTERS, METHODS OF MAKING, AND USE THEREOF | BRANDEIS UNIVERSITY (US) | 2024-08-08 | — | — | WO | claimed |
| WO-2024162422-A1 | TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT | ハウス食品グループ本社株式会社 | 2024-08-08 | — | — | WO | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| CN-116425838-A | Polypeptide compound and medical application thereof | 北京拓界生物医药科技有限公司 | 2023-07-14 | — | — | CN | claimed |
| CN-114605496-A | Polypeptide and application thereof, antibacterial drug and preparation method thereof | 华中科技大学 | 2022-06-10 | — | — | CN | claimed |
| US-20150132440-A1 | DIPEPTIDE AND TRIPEPTIDE COMPOSITIONS AND USES | JHO INTELLECTUAL PROPERTY HOLDINGS, LLC | 2015-05-14 | — | — | US | claimed |
| CN-103163269-B | Method for fast identifying fermented soy sauce and blended soy sauce | FOSHAN HAITIAN FLAVORING & FOOD CO LTD | 2014-12-17 | — | — | CN | claimed |
| CN-103163248-B | Method for identifying blended soy sauce | FOSHAN HAITIAN FLAVORING & FOOD CO LTD | 2014-05-28 | — | — | CN | claimed |
| CN-103163269-A | Method for fast identifying fermented soy sauce and blended soy sauce | FOSHAN HAITIAN FLAVORING & FOOD CO LTD | 2013-06-19 | — | — | CN | claimed |
| CN-103163248-A | Method for identifying blended soy sauce | FOSHAN HAITIAN FLAVORING & FOOD CO LTD | 2013-06-19 | — | — | CN | claimed |
| WO-2026107097-A1 | SELF-IMMOLATIVE LINKERS AND CONJUGATES THEREOF | ENLAZA THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| US-12622975-B2 | Peptide-conjugated prodrugs | BRANDEIS UNIVERSITY (US) | 2026-05-12 | — | — | US | disclosed |
| WO-2026087804-A1 | METHOD FOR PRODUCING SELF-ASSEMBLING DIPEPTIDES | FERTINAGRO BIOTECH, S.L. (ES) | 2026-04-30 | — | — | WO | disclosed |
| EP-0309971-A2 | New spergualin-related compound and pharmaceutical composition | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1989-04-05 | — | — | EP | disclosed |
| CN-87102538-A | New compound relevant and preparation method thereof with spergualin | — | 1987-11-18 | — | — | CN | disclosed |
| EP-0241797-A2 | Novel spergualin-related compounds and process for producing the same | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 1987-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622975-B2 | Peptide-conjugated prodrugs | PEPD, PAM, VIP | ALDH1A1 3596/4885ENPEP 18/4885L3MBTL1 184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.